tiprankstipranks
Trending News
More News >
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market
Advertisement

Benitec Biopharma (BNTC) Income Statement

Compare
298 Followers

Benitec Biopharma Income Statement

Last quarter (Q4 2025), Benitec Biopharma's total revenue was AU$556.00K, an increase of Infinity% from the same quarter last year. In Q4, Benitec Biopharma's net income was AU$-16.15M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 0.00AU$ 216.00KAU$ 75.00KAU$ 73.00KAU$ 59.00K
Gross Profit
AU$ -396.00KAU$ 108.00KAU$ -306.00KAU$ 64.00KAU$ -64.00K
Operating Expenses
AU$ 41.37MAU$ 22.38MAU$ 19.16MAU$ 17.92MAU$ 13.53M
Depreciation and Amortization
AU$ 69.33KAU$ 343.00KAU$ 381.00KAU$ 392.00KAU$ 424.00K
EBITDA
AU$ -41.77MAU$ -21.41MAU$ -19.15MAU$ -17.85MAU$ -13.45M
Operating Income
AU$ -41.77MAU$ -22.49MAU$ -19.08MAU$ -17.85MAU$ -13.60M
Other Income/Expenses
AU$ 3.85MAU$ 739.00KAU$ -481.00KAU$ -354.00KAU$ -286.00K
Pretax Income
AU$ -37.92MAU$ -21.75MAU$ -19.56MAU$ -18.21MAU$ -13.88M
Net Income
AU$ -37.92MAU$ -21.75MAU$ -19.56MAU$ -18.21MAU$ -13.88M
Per Share Metrics
Basic EPS
AU$ -1.05AU$ -2.68AU$ -14.12AU$ -19.31AU$ -27.27
Diluted EPS
AU$ -1.05AU$ -2.68AU$ -14.12AU$ -19.31AU$ -27.27
Weighted Average Shares Outstanding
36.21M 10.26M 1.39M 1.92M 1.01M
Weighted Average Shares Outstanding (Diluted)
36.21M 10.28M 1.39M 1.92M 1.01M
Currency in AUD

Benitec Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis